William Waldrop notified EVIO, Inc. of his resignation as Chief Executive Officer and Chair of the Board of Directors effective December 31, 2020. Mr. Waldrop will continue to serve as a consultant to the company to assist with transition to new CEO. Effective January 1, 2021, Lori Glauser, Chief Operating Officer and President, will serve as Interim Chief Executive Officer and Chair of the company. Ms. Glauser, age 51, has been Chief Operating Officer and Director of the company since the company’s inception in August, 2014. Ms. Glauser has 30 years’ experience in technology and strategic consulting. Ms. Glauser began her career as an engineer at Stone & Webster Engineering in 1991. In 1995 she joined Stone & Webster Management Consultants. From 2007 until 2014, Ms. Glauser held several roles in management consulting and advised several startup companies. Her positions included Senior Manager, Advisory Services at EY, Managing Consultant at IBM Global Business Services, Product Manager at Itron, Inc., and Associate Director at SNL Financial.
EVIO, Inc. is a diversified holding company. The Company provides analytical testing services to the agricultural and pharmaceutical industries, primarily for cannabis, hemp, and related products. The Company offers residential and commercial construction services. The Company also offers research and development and consulting services for participants in the cannabis and hemp industries. The Company tests products to verify the regulatory requirements for sale. Its subsidiaries include Smith Scientific Industries, LLC; Greenhaus Analytical Labs, LLC; Viridis Analytics, LLC; EVIO Labs OR, Inc.; C3 Labs, LLC; EVIO Labs Humboldt, LLC and Keystone Labs, Inc.
EVIO, INC. 
